Other Names for this Disease
- Sexual precocity
- Idiopathic sexual precocity
- Familial precocious puberty
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
Your QuestionAre there long term effects into adulthood from medicinal treatment of precocious puberty in a 2-3 year old child? Has there been any type of evidence that an adult that had received treatment for precocious puberty has any health problems related to that treatment?
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
Questions on this page
Precocious puberty is when a person's sexual and physical traits develop and mature earlier than normal. Normal puberty typically begins between ages 10 and 14 for girls, and ages 12 and 16 for boys. The start of puberty depends on various factors such as family history, nutrition and gender. The cause of precocious puberty is not always known. Some cases of precocious puberty are due to conditions that cause changes in the body's release of hormones. Treatment involves medications that can stop the release of sexual hormones.
Last updated: 12/21/2012
Several studies have looked at the long-term effects of treatment with hormone therapy on children with precocious puberty. Long-term hormone treatment has been found to be safe for the reproductive system and helpful in reaching target adult height levels. Additionally, there is little evidence suggesting that long term hormone treatment is associated with psychological or behavioral problems. More studies are needed to determine this association.
Last updated: 12/21/2012
- Precocious puberty. Medline Plus. 2011; http://www.nlm.nih.gov/medlineplus/ency/article/001168.htm. Accessed 12/21/2012.
- Pasquino AM, Pucarelli I, Accardo F, et al.. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.. J. Clin Endocrin Met. 2008; 93:190-5. http://www.ncbi.nlm.nih.gov/pubmed/17940112. Accessed 12/21/2012.
- Carel JC, Eugster E, Rogal A, et al. Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. Pediatrics. 2009; 123:752-762. http://pediatrics.aappublications.org/content/123/4/e752.long. Accessed 12/21/2012.